<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5286368 Figure_1-A</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Kaplan-Meier survival plot of cohorts of induced Vil Apc, Vil Apc Huwe1het and Vil Apc Huwe1hom mice. Deletion of Huwe1 led to a significant reduction in survival of these animals (Vil Apc vs Vil Apc Huwe1het / Vil Apc Huwe1hom, Log Rank, p &lt; 0.001, n &#8805; 10).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_1-B</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 1-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Wholemount isolation of small intestines from Vil Apc and Vil Apc Huwe1hom mice culled at clinical endpoint. Note the huge numbers of tiny macroscopic adenomas visible in the Vil Apc Huwe1hom intestine (red arrows).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_1-C</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 1-C</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) H&amp;E staining of intestinal cross sections from Vil Apc and Vil Apc Huwe1hom mice demonstrating the increased adenoma burden following Huwe1 deletion. Black arrows indicate individual adenomas. Scale bars = 200 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_1-D</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 1-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Quantification of total tumour numbers per gut in sacrificed Vil Apc, Vil Apc Huwe1het and Vil Apc Huwe1hom mice. Deletion of Huwe1 led to a significant increase in the number of tumours per gut (Mann Whitney, n &#8805; 5).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_2-A-D</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 2-A-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-D</infon>
    <passage>
      <offset>0</offset>
      <text>(a) H&amp;E staining of control and Huwe1 deleted intestinal epithelium. Shortened villi in Huwe1 deficient tissue are indicated. Scale bars = 100 &#181;m. (b) BrdU IHC of control and Huwe1 deleted intestinal epithelium. Scale bars = 100 &#181;m. (c) PAS staining identifying Goblet cells. No gross changes were observed. Scale bars = 100 &#181;m. (d) Lysozyme staining (Paneth cell marker) of control and Huwe1 deleted small intestine. Note the occurrence of lysozyme positive cells away from the crypt base (black arrows). Scale bars = 100 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_2-E</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Dual Periodic acid-Schiff / Alcian blue staining to identify Paneth cell secretory vesicles (light blue / pink - marked with black arrows) and goblet cells (dark blue / purple - marked with red arrows). Note Paneth cell secretory vesicles are restricted to crypt base in both control and Huwe1 deficient small intestines (inset - black arrows). Scale bars = 100&#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_2-F</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 2-F</infon>
    <infon key="sourcedata_figure_dir">Figure_2-F</infon>
    <passage>
      <offset>0</offset>
      <text>(f) MMP7 staining of control and Huwe1 deleted small intestine. Note MMP7 staining is restricted to crypt base in Huwe1 deficient intestines. Scale bars = 100&#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_3-A</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) HUWE1 and MYC Western blot analysis of epithelial cell extractions from control and Huwe1 deficient intestines. Levels of MYC protein are significantly increased in normal intestines lacking HUWE1 (Mann Whitney, p = 0.04, n = 3).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_3-B</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) QRT-PCR analysis of Myc expression in control and Huwe1 deficient intestines.</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_3-C</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) MYC IHC in tumours from Vil Apc and Vil Apc Huwe1hom mice. Scale bars = 50 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_3-D</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) MYC Western blot in protein extracts from Vil Apc and Vil Apc Huwe1hom tumours. Levels of MYC protein are significantly increased in tumours lacking HUWE1 (Mann Whitney, p = 0.04, n = 3).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_3-E</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(e) QRT-PCR analysis of Myc expression in tumours from Vil Apc and Vil Apc Huwe1hom mice.</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_4-A</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 4-A</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Kaplan-Meier survival plot of cohorts of induced Vil Apc Pten, Vil Apc Pten Huwe1, Vil Apc Pten Myc and Vil Apc Pten Huwe1 Myc mice. Heterozygous deletion of Myc led to a specific and significant increase in survival of Huwe1 deleted animals (Vil Apc Pten Huwe1 vs Vil Apc Pten Huwe1 Myc, Log Rank, p &lt; 0.001, n &#8805; 16).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_4-B</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 4-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Quantification of total tumour numbers per gut in sacrificed Vil Apc Pten, Vil Apc Pten Huwe1, Vil Apc Pten Myc and Vil Apc Pten Huwe1 Myc mice. Heterozygous deletion of Myc did not reduce the number of tumours in Huwe1 deleted mice (Vil Apc Pten Huwe1 vs Vil Apc Pten Huwe1 Myc. Mann Whitney, n &#8805; 10).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_4-C</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 4-C</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Kaplan-Meier survival plot of cohorts of induced AhCre-ERT Apc Pten and AhCre-ERT Apc Pten MycT58A mice. Overexpression of proteolytically stabilised MYC led to a significant reduction in survival (Log Rank, p &lt; 0.001, n = 14 vs 21).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_4-D</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 4-D</infon>
    <infon key="sourcedata_figure_dir">Figure_4-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Quantification of total tumour numbers per gut in sacrificed Apc Pten and Apc Pten MycT58A mice. Overexpression of proteolytically stabilised MYC did not increase the number of tumours in Apc Pten mice (Mann Whitney, n = 9 vs 19).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_5-A</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 5-A</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) H2AX Western blot in protein extracts from control and Huwe1 deficient intestinal epithelial cells. Band intensity relative to &#946;actin displayed under each lane (Mann-Whitney, p = 0.04, n = 3 vs 3).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_5-B</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 5-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) &#947;-H2AX IHC showing increased positivity in Huwe1 deleted intestinal cells. Scale bars = 50 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_5-C</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) &#947;-H2AX Western blot in protein extracts from control and Huwe1 deficient intestinal epithelial cells (Mann-Whitney, p = 0.04, n = 3 vs 3).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_5-D</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) &#947;-H2AX IHC of Vil Apc and Vil Apc Huwe1hom tumours, note increased positivity in Huwe1 deficient tumours. Scale bars = 50 &#181;m.</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_6-A-B</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 6-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>(a) Caspase 3 IHC of tumours from Lgr5 Apc and Lgr5 Apc Huwe1 mice either untreated or 6h post treatment with 7.5mg/kg cisplatin. Arrows identify caspase 3 positive cells. Scale bars = 50 &#181;m. (b) Quantification of cisplatin treatment showing a significant increase in apoptosis in Huwe1 deficient tumour cells (Mann-Whitney, n = 3 vs 5).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_6-C</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 6-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Comparison of somatic mutation rate (mutations / Mb) between human tumours carrying HUWE1 mutations or not. Note the significant increase in mutational burden in HUWE1 mutated tumours (Mann-Whitney, p = 0.0002, n &#8805; 15).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_6-D</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 6-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-D</infon>
    <passage>
      <offset>0</offset>
      <text>(d) Comparison of somatic mutation rate (mutations / Mb) between human tumours carrying HUWE1 mutations or not grouped according to MLH1 status. Note that the increased mutation rate is found primarily in tumours where MLH1 is not silenced indicating increased mutation rate (and HUWE1 mutation itself) is not due to silencing of MLH1 (Mann-Whitney, p = 0.0007, n &#8805; 11).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_6-E-F</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 6-E-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E-F</infon>
    <passage>
      <offset>0</offset>
      <text>(e) Survival analysis of colorectal cancer patients treated with adjuvant chemotherapy divided by HUWE1 expression levels. Note the lowest HUWE1 expressing quartile of patients respond significantly better to chemotherapy. (f) Survival analysis of colorectal cancer patients not treated with adjuvant chemotherapy divided by HUWE1 expression levels. Note the lowest HUWE1 expressing quartile of patients do not survive significantly longer than those expressing higher levels of HUWE1 if not treated with chemotherapy.</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_7-B</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Kaplan-Meier survival plot of cohorts of induced Lgr5 Apc and Lgr5 Apc Huwe1 mice. Deletion of Huwe1 led to a significant reduction in survival of these animals (Log Rank, p &lt; 0.001, n &#8805; 15).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_7-C-D</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 7-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Lysozyme IHC demonstrating increased lysozyme positive cell numbers in tumours from Lgr5 Apc Huwe1 mice. Scale bars = 200 &#181;m (low magnification), 100 &#181;m (high magnification inset). (d) OLFM4 IHC demonstrating expanded stem cell population in Lgr5 Apc Huwe1 tumours. Scale bars = 200 &#181;m (low magnification), 100 &#181;m (high magnification inset).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_8-A</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 8-A</infon>
    <infon key="sourcedata_figure_dir">Figure_8-A</infon>
    <passage>
      <offset>0</offset>
      <text>(a) MCL1 Western blot in protein extracts from Vil Apc and Vil Apc Huwe1hom tumours. Levels of MCL1 protein are significantly increased in tumours lacking HUWE1 (Mann Whitney, p = 0.04, n = 3).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_8-B</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 8-B</infon>
    <infon key="sourcedata_figure_dir">Figure_8-B</infon>
    <passage>
      <offset>0</offset>
      <text>(b) Kaplan-Meier survival plot of cohorts of induced Lgr5 Apc Huwe1 and Lgr5 Apc Huwe1 Mcl1 mice. Deletion of one copy of Mcl1 led to a significant increase in survival of these animals (Log Rank, p = 0.0052, n = 9 vs 10).</text>
    </passage>
  </document>
  <document>
    <id>5286368 Figure_8-C</id>
    <infon key="sourcedata_document">2603</infon>
    <infon key="doi">10.15252/emmm.201606684</infon>
    <infon key="pmc_id">5286368</infon>
    <infon key="figure">Figure 8-C</infon>
    <infon key="sourcedata_figure_dir">Figure_8-C</infon>
    <passage>
      <offset>0</offset>
      <text>(c) Ratio of adenoma / indolent lesions observed in Lgr5 Apc Huwe1 and Lgr5 Apc Huwe1 Mcl1het mice. Note the decreased ration of adenoma / indolent lesions observed upon Mcl1 deletion (Mann-Whitney, p=0.0281, n = 8 v 8).</text>
    </passage>
  </document>
</collection>
